The emerging treatment of tirzepatide peptide represents a major breakthrough in the handling of the condition. Unlike existing drugs, tirzepatide impacts multiple pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – providing improved sugar regulation and anticipated reducti